Jennifer K. Straughen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennifer K. Straughen has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Andrea E. Cassidy-Bushrow
Department of Public Health Sciences, Henry Ford Health, Detroit, MI, USA
7 shared publications Andrea E. Cassidy-Bushrow
Public Health Sciences, Henry Ford Health, Detroit, MI, USA
6 shared publicationsGanesa Wegienka
Department of Public Health Sciences Henry Ford Health + Michigan State University Health Sciences Detroit Michigan USA
4 shared publications- Albert M. Levin
Department of Public Health Sciences, Henry Ford Health, Detroit, Michigan, USA
3 shared publications - Alexandra Rene Sitarik
Department of Public Health Sciences, Henry Ford Health, Detroit, MI 48202, USA
3 shared publications - Carolyn M. Salafia
Placental Analytics, LLC, New Rochelle, NY, USA; Institute for Basic Research, Staten Island, NY, USA
3 shared publications
Latest Publications
- Open Access
- 19 September 2026
- Published by BMJ in BMJ Paediatrics Open
- Vol. 10 (1) , e004506
Prenatal urinary BTEX metabolite levels and length of gestation: preliminary results from a metropolitan Detroit birth cohort
While the common volatile organic compound mixture benzene, toluene, ethylbenzene and xylene (BTEX) is associated with preterm birth (PTB), most evidence derives from estimated rather than direct measures of exposure. Metabolites of BTEX were measured in urine samples from pregnant participants (N=40) to conduct a preliminary association study of BTEX metabolites and length of gestation. Metabolites of ethylbenzene (phenylglyoxylic acid (PGA)) and xylene (methylhippuric acid (MHA)) were negatively correlated with gestational length; the Spearman correlation coefficient (ρ) for PGA and gestational length was ρ=−0.37 (p=0.018) and for MHA and gestational length was ρ=−0.35 (p=0.026). Preliminary findings suggest prenatal ethylbenzene and xylene exposure may be associated with shorter gestational length. Ongoing work in a larger sample is underway to examine associations between BTEX metabolites, measured longitudinally across pregnancy, and PTB.
- 19 September 2026
- Published by BMJ in BMJ Paediatrics Open
- Vol. 10 (1) , e004506
Open AccessPrenatal urinary BTEX metabolite levels and length of gestation: preliminary results from a metropolitan Detroit birth cohort
While the common volatile organic compound mixture benzene, toluene, ethylbenzene and xylene (BTEX) is associated with preterm birth (PTB), most evidence derives from estimated rather than direct measures of exposure. Metabolites of BTEX were measured in urine samples from pregnant participants (N=40) to conduct a preliminary association study of BTEX metabolites and length of gestation. Metabolites of ethylbenzene (phenylglyoxylic acid (PGA)) and xylene (methylhippuric acid (MHA)) were negatively correlated with gestational length; the Spearman correlation coefficient (ρ) for PGA and gestational length was ρ=−0.37 (p=0.018) and for MHA and gestational length was ρ=−0.35 (p=0.026). Preliminary findings suggest prenatal ethylbenzene and xylene exposure may be associated with shorter gestational length. Ongoing work in a larger sample is underway to examine associations between BTEX metabolites, measured longitudinally across pregnancy, and PTB.
- Open Access
- 16 September 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (9) , e70485
The Association of Longitudinal Atopic Dermatitis Phenotypes and Attention‐Deficit/Hyperactivity Disorder in Childhood
- 16 September 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (9) , e70485
Open AccessThe Association of Longitudinal Atopic Dermatitis Phenotypes and Attention‐Deficit/Hyperactivity Disorder in Childhood
- Open Access
- 24 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e87272
Investigating the Association Between Volatile Organic Compounds and Preterm Birth in Detroit, Michigan: Protocol for the Center for Leadership in Environmental Awareness and Research Birth Cohort Study
Background: Preterm birth (PTB), or birth before 37 weeks of gestation, remains a significant public health issue in the United States, particularly in Detroit, Michigan. Growing evidence suggests that volatile organic compounds (VOCs), aromatic or chlorinated organic compounds that vaporize readily, may influence PTB risk. However, much of this prior work is limited by indirect VOC exposure estimates (eg, assignment based on maternal residential address), single-point or cumulative exposure estimates during pregnancy, or limited consideration of potential mechanistic factors. Objective: The Center for Leadership in Environmental Awareness and Research (CLEAR) birth cohort has been designed to test the hypotheses that prenatal VOC exposures, measured as VOC metabolites in maternal urine, increase the risk of PTB; that VOC exposures are associated with maternal inflammation and placental function measures; that associations between prenatal VOC exposures and PTB may be mediated by these maternal inflammation and placental function measures; and that there are neighborhood-level factors that may increase the risk of VOC exposure during pregnancy. Methods: A prospective cohort of 1075 pregnant patients receiving prenatal care at Henry Ford Health will be recruited. Pregnant patients residing in Detroit or receiving prenatal care at a Detroit-based Henry Ford Health women’s health clinic are eligible. Pregnant patients are followed until delivery. Up to 3 urine and blood samples (collected during early, mid, and late pregnancy) are obtained for measurement of VOC metabolites and inflammatory biomarkers, respectively. The placenta is obtained after delivery for epigenomic and transcriptomic measurement. Surveys are administered to pregnant participants to assess a variety of lifestyle, psychosocial, medical, residential, and other factors. Address information collected from both surveys and electronic medical records across pregnancy will be used to identify potential sources of VOC exposure. The electronic medical record is used to obtain medical and delivery data, including infant sex, date of delivery, and gestational age (GA) at delivery. PTB, the primary study outcome, is defined as GA at delivery <37 weeks. A nested case-control approach (frequency matching PTB cases 1:1 with full-term controls [GA at delivery ≥37 weeks] based on infant sex and maternal race) will be applied. Statistical methods, including logistic regression, linear mixed methods, and geographically weighted regression models, as well as chemical mixture approaches, will be used. Results: Funding began September 2022 and recruitment commenced November 2023. Through April 22, 2026, a total of 468 pregnant patients have consented to participate in the CLEAR birth cohort, and recruitment is ongoing. Conclusions: The CLEAR cohort will provide novel data on the role of VOCs during pregnancy in the risk of PTB. Additionally, the role of VOC exposures during pregnancy in maternal inflammation and placental function will be examined. Finally, potential sources of VOC exposures, which could be targets for environmental remediation, will be identified.
- 24 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e87272
Open AccessInvestigating the Association Between Volatile Organic Compounds and Preterm Birth in Detroit, Michigan: Protocol for the Center for Leadership in Environmental Awareness and Research Birth Cohort Study
Background: Preterm birth (PTB), or birth before 37 weeks of gestation, remains a significant public health issue in the United States, particularly in Detroit, Michigan. Growing evidence suggests that volatile organic compounds (VOCs), aromatic or chlorinated organic compounds that vaporize readily, may influence PTB risk. However, much of this prior work is limited by indirect VOC exposure estimates (eg, assignment based on maternal residential address), single-point or cumulative exposure estimates during pregnancy, or limited consideration of potential mechanistic factors. Objective: The Center for Leadership in Environmental Awareness and Research (CLEAR) birth cohort has been designed to test the hypotheses that prenatal VOC exposures, measured as VOC metabolites in maternal urine, increase the risk of PTB; that VOC exposures are associated with maternal inflammation and placental function measures; that associations between prenatal VOC exposures and PTB may be mediated by these maternal inflammation and placental function measures; and that there are neighborhood-level factors that may increase the risk of VOC exposure during pregnancy. Methods: A prospective cohort of 1075 pregnant patients receiving prenatal care at Henry Ford Health will be recruited. Pregnant patients residing in Detroit or receiving prenatal care at a Detroit-based Henry Ford Health women’s health clinic are eligible. Pregnant patients are followed until delivery. Up to 3 urine and blood samples (collected during early, mid, and late pregnancy) are obtained for measurement of VOC metabolites and inflammatory biomarkers, respectively. The placenta is obtained after delivery for epigenomic and transcriptomic measurement. Surveys are administered to pregnant participants to assess a variety of lifestyle, psychosocial, medical, residential, and other factors. Address information collected from both surveys and electronic medical records across pregnancy will be used to identify potential sources of VOC exposure. The electronic medical record is used to obtain medical and delivery data, including infant sex, date of delivery, and gestational age (GA) at delivery. PTB, the primary study outcome, is defined as GA at delivery <37 weeks. A nested case-control approach (frequency matching PTB cases 1:1 with full-term controls [GA at delivery ≥37 weeks] based on infant sex and maternal race) will be applied. Statistical methods, including logistic regression, linear mixed methods, and geographically weighted regression models, as well as chemical mixture approaches, will be used. Results: Funding began September 2022 and recruitment commenced November 2023. Through April 22, 2026, a total of 468 pregnant patients have consented to participate in the CLEAR birth cohort, and recruitment is ongoing. Conclusions: The CLEAR cohort will provide novel data on the role of VOCs during pregnancy in the risk of PTB. Additionally, the role of VOC exposures during pregnancy in maternal inflammation and placental function will be examined. Finally, potential sources of VOC exposures, which could be targets for environmental remediation, will be identified.
- Open Access
- 9 June 2026
- Published by Springer Nature in Journal of Exposure Science & Environmental Epidemiology
- Vol. 36 (5) , 888-898
Comparative Analysis of Report-back of Research Results Strategies for Personal Chemical Exposure Data
Report-back of research results (RBRR) is ethically supported and highly requested by participants, yet lacks broadly transferable guidelines for RBRR. Effective RBRR must be responsive to target audience needs and may not be addressed by a 'one-size-fits-all' approach. Within a subset of our 19 studies on RBRR, we had the unique opportunity to carry out a comparative analysis of RBRR strategies across cohorts with similar development and evaluation methods, yet distinct in life stage, geography, number and type of chemicals assessed, and community contexts. We highlight key outcomes from three environmental health studies: an ongoing New York, NY cohort (Fair Start; n = 486) and a Detroit, MI cohort (CLEAR; n = 34) assessing exposure to ambient urban pollution during pregnancy, and a longitudinal cohort in Houston, TX (Houston-3H; n = 312) following Hurricane Harvey. Focus group and survey data were analyzed to identify lessons learned and explore how RBRR supports understanding of environmental health. Commonalities emerged in RBRR development, design, organization, and data visualization, as well as in how RBRR can contribute to an understanding of health-environment connections. Differences included preferences for individual versus community level findings, as well as distinguishable contextual considerations. For pregnancy cohorts, messaging was framed with cultural sensitivity, and to avoid unintended consequences of parental guilt due to prenatal exposures. In the post-disaster Houston-3H study, participants requested additional transparency regarding sampling design and study rationale. All RBRR case studies reported chemicals without known regulatory or health guidelines, so results were contextualized within the study population. Participants across cohorts requested multi-study comparisons to better understand their results beyond their communities. While foundational RBRR elements (e.g. plain language, graphic organizers) may supersede cohort-specific differences, RBRR should be personalized to encompass perceptions of health across different life-stage, cultural, and environmental contexts. We had the unique opportunity to compare different studies, accounting for different exposure experiences, life stages, chemicals assessed, and RBRR evaluation methods. To our knowledge, this is the first multi-state study reporting back wristband data, used to assess transferable strategies across populations, and how RBRR supports participant understanding of environmental influences on health. Due to the differences between disaster-impacted and peripartum individuals in this subset of case studies, comparisons can inform transferable characteristics of developing RBRR as well as study specific attributes that are responsive to unique contexts.
- 9 June 2026
- Published by Springer Nature in Journal of Exposure Science & Environmental Epidemiology
- Vol. 36 (5) , 888-898
Open AccessComparative Analysis of Report-back of Research Results Strategies for Personal Chemical Exposure Data
Report-back of research results (RBRR) is ethically supported and highly requested by participants, yet lacks broadly transferable guidelines for RBRR. Effective RBRR must be responsive to target audience needs and may not be addressed by a 'one-size-fits-all' approach. Within a subset of our 19 studies on RBRR, we had the unique opportunity to carry out a comparative analysis of RBRR strategies across cohorts with similar development and evaluation methods, yet distinct in life stage, geography, number and type of chemicals assessed, and community contexts. We highlight key outcomes from three environmental health studies: an ongoing New York, NY cohort (Fair Start; n = 486) and a Detroit, MI cohort (CLEAR; n = 34) assessing exposure to ambient urban pollution during pregnancy, and a longitudinal cohort in Houston, TX (Houston-3H; n = 312) following Hurricane Harvey. Focus group and survey data were analyzed to identify lessons learned and explore how RBRR supports understanding of environmental health. Commonalities emerged in RBRR development, design, organization, and data visualization, as well as in how RBRR can contribute to an understanding of health-environment connections. Differences included preferences for individual versus community level findings, as well as distinguishable contextual considerations. For pregnancy cohorts, messaging was framed with cultural sensitivity, and to avoid unintended consequences of parental guilt due to prenatal exposures. In the post-disaster Houston-3H study, participants requested additional transparency regarding sampling design and study rationale. All RBRR case studies reported chemicals without known regulatory or health guidelines, so results were contextualized within the study population. Participants across cohorts requested multi-study comparisons to better understand their results beyond their communities. While foundational RBRR elements (e.g. plain language, graphic organizers) may supersede cohort-specific differences, RBRR should be personalized to encompass perceptions of health across different life-stage, cultural, and environmental contexts. We had the unique opportunity to compare different studies, accounting for different exposure experiences, life stages, chemicals assessed, and RBRR evaluation methods. To our knowledge, this is the first multi-state study reporting back wristband data, used to assess transferable strategies across populations, and how RBRR supports participant understanding of environmental influences on health. Due to the differences between disaster-impacted and peripartum individuals in this subset of case studies, comparisons can inform transferable characteristics of developing RBRR as well as study specific attributes that are responsive to unique contexts.
- Open Access
- 11 July 2025
- Published by Wiley in Pediatric Investigation
- Vol. 9 (4) , 372-382
Sex‐specific associations between hypertensive disorders in pregnancy and fetal and placental weight
Importance: Hypertensive disorders in pregnancy (HDPs) are common and increase the risk of maternal and fetal morbidity and mortality. HDPs may impact fetal growth; however, sex‐specific effects have been understudied. Objective: To examine whether sex‐specific differences exist in the association between HDPs and birthweight and placental weight. Methods: A birth cohort based in Detroit, Michigan, was utilized ( n = 1258). HDPs and birthweight were abstracted from medical records; placental weight was obtained from placental pathology reports. Linear regression was used to model sex‐specific associations, after multiple imputation, confounder adjustment, and inverse probability weighting to account for selection bias. Results: The primary analysis included all pregnancies ( n = 853), while the secondary analysis included those sent for placental pathology, reflective of complicated pregnancies ( n = 165). In the primary analysis subset, males of mothers with gestational hypertension had birthweight Z‐scores that were on average 0.90 standard deviations higher, but this association was not found among females (interaction P = 0.019; male β [95% confidence interval {CI}]: 0.90 [0.28, 1.52]; female β [95% CI]: −0.12 [−0.65, 0.41]). However, in the subset of complicated pregnancies, female mothers with gestational hypertension also had reduced birthweight (interaction P = 0.013; male β [95% CI]: 1.50 [0.15, 2.86]; female β [95% CI]: −1.14 [−2.13, −0.16]). For fetoplacental weight ratio, any HDP was associated with a lower ratio among females only (interaction P = 0.028; male β [95% CI]: −0.04 [−0.71, 0.64]; female β [95% CI]: −0.95 [−1.57, −0.33]). Interpretation: Male fetuses may prioritize growth, whereas females may prioritize placental development when exposed to HDPs.
- 11 July 2025
- Published by Wiley in Pediatric Investigation
- Vol. 9 (4) , 372-382
Open AccessSex‐specific associations between hypertensive disorders in pregnancy and fetal and placental weight
Importance: Hypertensive disorders in pregnancy (HDPs) are common and increase the risk of maternal and fetal morbidity and mortality. HDPs may impact fetal growth; however, sex‐specific effects have been understudied. Objective: To examine whether sex‐specific differences exist in the association between HDPs and birthweight and placental weight. Methods: A birth cohort based in Detroit, Michigan, was utilized ( n = 1258). HDPs and birthweight were abstracted from medical records; placental weight was obtained from placental pathology reports. Linear regression was used to model sex‐specific associations, after multiple imputation, confounder adjustment, and inverse probability weighting to account for selection bias. Results: The primary analysis included all pregnancies ( n = 853), while the secondary analysis included those sent for placental pathology, reflective of complicated pregnancies ( n = 165). In the primary analysis subset, males of mothers with gestational hypertension had birthweight Z‐scores that were on average 0.90 standard deviations higher, but this association was not found among females (interaction P = 0.019; male β [95% confidence interval {CI}]: 0.90 [0.28, 1.52]; female β [95% CI]: −0.12 [−0.65, 0.41]). However, in the subset of complicated pregnancies, female mothers with gestational hypertension also had reduced birthweight (interaction P = 0.013; male β [95% CI]: 1.50 [0.15, 2.86]; female β [95% CI]: −1.14 [−2.13, −0.16]). For fetoplacental weight ratio, any HDP was associated with a lower ratio among females only (interaction P = 0.028; male β [95% CI]: −0.04 [−0.71, 0.64]; female β [95% CI]: −0.95 [−1.57, −0.33]). Interpretation: Male fetuses may prioritize growth, whereas females may prioritize placental development when exposed to HDPs.
- Open Access
- 5 July 2025
- Published by SAGE Publications in Women's Health
- Vol. 21
Activity tracking devices in pregnancy: Understanding the participant experience in a longitudinal birth cohort
Background: Improving understanding of physical activity (PA) during pregnancy can inform future interventions and support the delivery of high-quality prenatal care. Objectives: Within the longitudinal birth cohort Research Enterprise to Advance Children’s Health (REACH), the sub-study REACH-Fitbit sought to understand the prenatal experiences of utilizing an activity monitoring device and best practices for receiving PA information. Design: REACH recruits gravid patients ⩾18 years old receiving prenatal care and planning to deliver at predefined hospitals. REACH-Fitbit participants had to be <20 weeks gestation with access to a Bluetooth-enabled device. Recruitment (self-selection) for focus groups occurred from completed REACH-Fitbit participants (e.g., delivered their baby). Methods: A semi-structured moderator guide was utilized to capture feedback on experiences, adherence to protocols, resources, and best practices for measuring PA during pregnancy. Two groups of six participants participated virtually, which included conversations about the overall participant experience, compliance with protocols, and opportunities for knowledge dissemination about PA. Results: The majority of focus group participants identified as Black, were between 20 and 29 years of age, and had positive feelings about the Fitbit, finding it usable and functional. Participants felt protocol compliance was facilitated by text message reminders and research team support, while barriers included Fitbit application problems, busy schedules, and forgetting. Participants preferred to receive PA information from a trusted healthcare source (e.g., doctor, nurse, or other healthcare provider), though most participants (57%) did not receive PA information during prenatal care. Participants were interested in learning about the safety, type, and amount of prenatal PA in which to engage. Conclusion: Findings presented here can support compliance in future studies or PA interventions utilizing similar technology. Incentives for compliance with study protocols and enhanced communication with the research team can improve participant engagement. Future work will address the need to communicate the interests of pregnant persons to clinical care teams, specifically, improvements to how providers share information on PA.
- 5 July 2025
- Published by SAGE Publications in Women's Health
- Vol. 21
Open AccessActivity tracking devices in pregnancy: Understanding the participant experience in a longitudinal birth cohort
Background: Improving understanding of physical activity (PA) during pregnancy can inform future interventions and support the delivery of high-quality prenatal care. Objectives: Within the longitudinal birth cohort Research Enterprise to Advance Children’s Health (REACH), the sub-study REACH-Fitbit sought to understand the prenatal experiences of utilizing an activity monitoring device and best practices for receiving PA information. Design: REACH recruits gravid patients ⩾18 years old receiving prenatal care and planning to deliver at predefined hospitals. REACH-Fitbit participants had to be <20 weeks gestation with access to a Bluetooth-enabled device. Recruitment (self-selection) for focus groups occurred from completed REACH-Fitbit participants (e.g., delivered their baby). Methods: A semi-structured moderator guide was utilized to capture feedback on experiences, adherence to protocols, resources, and best practices for measuring PA during pregnancy. Two groups of six participants participated virtually, which included conversations about the overall participant experience, compliance with protocols, and opportunities for knowledge dissemination about PA. Results: The majority of focus group participants identified as Black, were between 20 and 29 years of age, and had positive feelings about the Fitbit, finding it usable and functional. Participants felt protocol compliance was facilitated by text message reminders and research team support, while barriers included Fitbit application problems, busy schedules, and forgetting. Participants preferred to receive PA information from a trusted healthcare source (e.g., doctor, nurse, or other healthcare provider), though most participants (57%) did not receive PA information during prenatal care. Participants were interested in learning about the safety, type, and amount of prenatal PA in which to engage. Conclusion: Findings presented here can support compliance in future studies or PA interventions utilizing similar technology. Incentives for compliance with study protocols and enhanced communication with the research team can improve participant engagement. Future work will address the need to communicate the interests of pregnant persons to clinical care teams, specifically, improvements to how providers share information on PA.
- Open Access
- 6 June 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e71587
Mapping the Level of Evidence of Prenatal, Childhood, and Adolescent Exposure to Volatile Organic Compounds and Health Outcomes: Protocol for a Scoping Review
Background: Volatile organic compounds (VOCs) are a diverse group of organic chemicals with widespread presence in daily life. VOCs may have detrimental health effects on humans, particularly during critical periods such as pregnancy, childhood, and adolescence. Although the body of evidence is growing, significant gaps remain in the current understanding of the associations of VOCs on health across these developmental stages. Moreover, existing reviews focused on specific VOCs or individual health conditions, highlighting the need for a comprehensive summary of the current literature to stimulate further research. Objective: This ongoing scoping review aims to map the current evidence concerning exposure to VOCs and their associations with pregnancy outcomes and health during pregnancy, childhood, and adolescence. Methods: This review will consider studies investigating potential health effects related to exposures to either total VOCs or any of the following 6 specific VOCs: benzene, toluene, ethylbenzene, xylene, trichloroethylene, and tetrachloroethylene or perchloroethylene during critical windows from pregnancy through adolescence. Original articles published in English from January 1, 2000, through the end of the scoping review period, will be included. We will follow the Joanna Briggs Institute methodology for scoping reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The literature search will use the Ovid MEDLINE, Embase, and Web of Science databases to identify relevant citations. The following steps of the review will be managed through the Covidence platform. A total of 2 reviewers will independently conduct a rapid screening of paper titles, before evaluating the abstracts and full texts to determine which articles will proceed to the data extraction stage. In case of discrepancies during these steps, the reviewers will discuss to reach a consensus, and a third reviewer may intervene if needed. Reviewers will provide commentaries on their findings from the included studies and suggest areas of interest for future studies. Results: The literature search yielded a total of 7332 citations published during the period January 1, 2000, to July 25, 2024. After the title screening and reading the abstract and full text, 274 papers were selected for the data extraction phase, which is currently underway. Upon completion of the library’s updated literature search, covering July 26, 2024, to the present, we will proceed with data analysis and manuscript writing for submission to a peer-reviewed journal. Conclusions: The results are expected to summarize the current state of knowledge on the association of VOCs with health at critical life stages (pregnancy, childhood, and adolescence). We anticipate identifying gaps in the literature as well that could guide future research priorities. Trial Registration: OSF Registries 10.17605/OSF.IO/EP73G; https://osf.io/ep73g International Registered Report Identifier (IRRID): DERR1-10.2196/71587
- 6 June 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e71587
Open AccessMapping the Level of Evidence of Prenatal, Childhood, and Adolescent Exposure to Volatile Organic Compounds and Health Outcomes: Protocol for a Scoping Review
Background: Volatile organic compounds (VOCs) are a diverse group of organic chemicals with widespread presence in daily life. VOCs may have detrimental health effects on humans, particularly during critical periods such as pregnancy, childhood, and adolescence. Although the body of evidence is growing, significant gaps remain in the current understanding of the associations of VOCs on health across these developmental stages. Moreover, existing reviews focused on specific VOCs or individual health conditions, highlighting the need for a comprehensive summary of the current literature to stimulate further research. Objective: This ongoing scoping review aims to map the current evidence concerning exposure to VOCs and their associations with pregnancy outcomes and health during pregnancy, childhood, and adolescence. Methods: This review will consider studies investigating potential health effects related to exposures to either total VOCs or any of the following 6 specific VOCs: benzene, toluene, ethylbenzene, xylene, trichloroethylene, and tetrachloroethylene or perchloroethylene during critical windows from pregnancy through adolescence. Original articles published in English from January 1, 2000, through the end of the scoping review period, will be included. We will follow the Joanna Briggs Institute methodology for scoping reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The literature search will use the Ovid MEDLINE, Embase, and Web of Science databases to identify relevant citations. The following steps of the review will be managed through the Covidence platform. A total of 2 reviewers will independently conduct a rapid screening of paper titles, before evaluating the abstracts and full texts to determine which articles will proceed to the data extraction stage. In case of discrepancies during these steps, the reviewers will discuss to reach a consensus, and a third reviewer may intervene if needed. Reviewers will provide commentaries on their findings from the included studies and suggest areas of interest for future studies. Results: The literature search yielded a total of 7332 citations published during the period January 1, 2000, to July 25, 2024. After the title screening and reading the abstract and full text, 274 papers were selected for the data extraction phase, which is currently underway. Upon completion of the library’s updated literature search, covering July 26, 2024, to the present, we will proceed with data analysis and manuscript writing for submission to a peer-reviewed journal. Conclusions: The results are expected to summarize the current state of knowledge on the association of VOCs with health at critical life stages (pregnancy, childhood, and adolescence). We anticipate identifying gaps in the literature as well that could guide future research priorities. Trial Registration: OSF Registries 10.17605/OSF.IO/EP73G; https://osf.io/ep73g International Registered Report Identifier (IRRID): DERR1-10.2196/71587
- Open Access
- 29 January 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Mapping the Level of Evidence of Prenatal, Childhood, and Adolescent Exposure to Volatile Organic Compounds and Health Outcomes: Protocol for a Scoping Review (Preprint)
BACKGROUND Volatile organic compounds (VOCs) are a diverse group of organic chemicals with widespread presence in daily life. VOCs may have detrimental health effects on humans, particularly during critical periods such as pregnancy, childhood, and adolescence. Although the body of evidence is growing, significant gaps remain in the current understanding of the associations of VOCs on health across these developmental stages. Moreover, existing reviews focused on specific VOCs or individual health conditions, highlighting the need for a comprehensive summary of the current literature to stimulate further research. OBJECTIVE This ongoing scoping review aims to map the current evidence concerning exposure to VOCs and their associations with pregnancy outcomes and health during pregnancy, childhood, and adolescence. METHODS This review will consider studies investigating potential health effects related to exposures to either total VOCs or any of the following 6 specific VOCs: benzene, toluene, ethylbenzene, xylene, trichloroethylene, and tetrachloroethylene or perchloroethylene during critical windows from pregnancy through adolescence. Original articles published in English from January 1, 2000, through the end of the scoping review period, will be included. We will follow the Joanna Briggs Institute methodology for scoping reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The literature search will use the Ovid MEDLINE, Embase, and Web of Science databases to identify relevant citations. The following steps of the review will be managed through the Covidence platform. A total of 2 reviewers will independently conduct a rapid screening of paper titles, before evaluating the abstracts and full texts to determine which articles will proceed to the data extraction stage. In case of discrepancies during these steps, the reviewers will discuss to reach a consensus, and a third reviewer may intervene if needed. Reviewers will provide commentaries on their findings from the included studies and suggest areas of interest for future studies. RESULTS The literature search yielded a total of 7332 citations published during the period January 1, 2000, to July 25, 2024. After the title screening and reading the abstract and full text, 274 papers were selected for the data extraction phase, which is currently underway. Upon completion of the library’s updated literature search, covering July 26, 2024, to the present, we will proceed with data analysis and manuscript writing for submission to a peer-reviewed journal. CONCLUSIONS The results are expected to summarize the current state of knowledge on the association of VOCs with health at critical life stages (pregnancy, childhood, and adolescence). We anticipate identifying gaps in the literature as well that could guide future research priorities. CLINICALTRIAL OSF Registries 10.17605/OSF.IO/EP73G; https://osf.io/ep73g INTERNATIONAL REGISTERED REPORT DERR1-10.2196/71587
- 29 January 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMapping the Level of Evidence of Prenatal, Childhood, and Adolescent Exposure to Volatile Organic Compounds and Health Outcomes: Protocol for a Scoping Review (Preprint)
BACKGROUND Volatile organic compounds (VOCs) are a diverse group of organic chemicals with widespread presence in daily life. VOCs may have detrimental health effects on humans, particularly during critical periods such as pregnancy, childhood, and adolescence. Although the body of evidence is growing, significant gaps remain in the current understanding of the associations of VOCs on health across these developmental stages. Moreover, existing reviews focused on specific VOCs or individual health conditions, highlighting the need for a comprehensive summary of the current literature to stimulate further research. OBJECTIVE This ongoing scoping review aims to map the current evidence concerning exposure to VOCs and their associations with pregnancy outcomes and health during pregnancy, childhood, and adolescence. METHODS This review will consider studies investigating potential health effects related to exposures to either total VOCs or any of the following 6 specific VOCs: benzene, toluene, ethylbenzene, xylene, trichloroethylene, and tetrachloroethylene or perchloroethylene during critical windows from pregnancy through adolescence. Original articles published in English from January 1, 2000, through the end of the scoping review period, will be included. We will follow the Joanna Briggs Institute methodology for scoping reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The literature search will use the Ovid MEDLINE, Embase, and Web of Science databases to identify relevant citations. The following steps of the review will be managed through the Covidence platform. A total of 2 reviewers will independently conduct a rapid screening of paper titles, before evaluating the abstracts and full texts to determine which articles will proceed to the data extraction stage. In case of discrepancies during these steps, the reviewers will discuss to reach a consensus, and a third reviewer may intervene if needed. Reviewers will provide commentaries on their findings from the included studies and suggest areas of interest for future studies. RESULTS The literature search yielded a total of 7332 citations published during the period January 1, 2000, to July 25, 2024. After the title screening and reading the abstract and full text, 274 papers were selected for the data extraction phase, which is currently underway. Upon completion of the library’s updated literature search, covering July 26, 2024, to the present, we will proceed with data analysis and manuscript writing for submission to a peer-reviewed journal. CONCLUSIONS The results are expected to summarize the current state of knowledge on the association of VOCs with health at critical life stages (pregnancy, childhood, and adolescence). We anticipate identifying gaps in the literature as well that could guide future research priorities. CLINICALTRIAL OSF Registries 10.17605/OSF.IO/EP73G; https://osf.io/ep73g INTERNATIONAL REGISTERED REPORT DERR1-10.2196/71587
- Open Access
- 23 February 2024
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 21 (3) , 256
The Impact of Environmental Benzene, Toluene, Ethylbenzene, and Xylene Exposure on Blood-Based DNA Methylation Profiles in Pregnant African American Women from Detroit
African American women in the United States have a high risk of adverse pregnancy outcomes. DNA methylation is a potential mechanism by which exposure to BTEX (benzene, toluene, ethylbenzene, and xylenes) may cause adverse pregnancy outcomes. Data are from the Maternal Stress Study, which recruited African American women in the second trimester of pregnancy from February 2009 to June 2010. DNA methylation was measured in archived DNA from venous blood collected in the second trimester. Trimester-specific exposure to airshed BTEX was estimated using maternal self-reported addresses and geospatial models of ambient air pollution developed as part of the Geospatial Determinants of Health Outcomes Consortium. Among the 64 women with exposure and outcome data available, 46 differentially methylated regions (DMRs) were associated with BTEX exposure (FDR adjusted p-value < 0.05) using a DMR-based epigenome-wide association study approach. Overall, 89% of DMRs consistently exhibited hypomethylation with increasing BTEX exposure. Biological pathway analysis identified 11 enriched pathways, with the top 3 involving gamma-aminobutyric acid receptor signaling, oxytocin in brain signaling, and the gustation pathway. These findings highlight the potential impact of BTEX on DNA methylation in pregnant women.
- 23 February 2024
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 21 (3) , 256
Open AccessThe Impact of Environmental Benzene, Toluene, Ethylbenzene, and Xylene Exposure on Blood-Based DNA Methylation Profiles in Pregnant African American Women from Detroit
African American women in the United States have a high risk of adverse pregnancy outcomes. DNA methylation is a potential mechanism by which exposure to BTEX (benzene, toluene, ethylbenzene, and xylenes) may cause adverse pregnancy outcomes. Data are from the Maternal Stress Study, which recruited African American women in the second trimester of pregnancy from February 2009 to June 2010. DNA methylation was measured in archived DNA from venous blood collected in the second trimester. Trimester-specific exposure to airshed BTEX was estimated using maternal self-reported addresses and geospatial models of ambient air pollution developed as part of the Geospatial Determinants of Health Outcomes Consortium. Among the 64 women with exposure and outcome data available, 46 differentially methylated regions (DMRs) were associated with BTEX exposure (FDR adjusted p-value < 0.05) using a DMR-based epigenome-wide association study approach. Overall, 89% of DMRs consistently exhibited hypomethylation with increasing BTEX exposure. Biological pathway analysis identified 11 enriched pathways, with the top 3 involving gamma-aminobutyric acid receptor signaling, oxytocin in brain signaling, and the gustation pathway. These findings highlight the potential impact of BTEX on DNA methylation in pregnant women.
- 28 July 2023
- Published by Elsevier in Environmental Research
- Vol. 236 (Pt 2) , 116772
Associations between area-level arsenic exposure and adverse birth outcomes: An Echo-wide cohort analysis
- 28 July 2023
- Published by Elsevier in Environmental Research
- Vol. 236 (Pt 2) , 116772
Associations between area-level arsenic exposure and adverse birth outcomes: An Echo-wide cohort analysis